Clinical Trial Update: Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating the toxicity of combining Bacillus Calmette-Guérin (BCG) with aminophylline for bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Aminophylline (aminophylline)
• Bacillus Calmette-Guérin (Bacillus Calmette-Guérin)

Snippet

Sponsor: University of Virginia | Conditions: Bladder Cancer | EARLY_Phase 1 | Status: COMPLETED